Nine-year-old New Yorker volunteers for COVID vax trial

3

An upstate boy is a COVID-19 vaccine pioneer, according to a report.

Walker Clary volunteered to participate in a pharmaceutical trial to “test the safety and effectiveness” of the Moderna vaccine for those aged six months to 12 years, according to syracuse.com

Walker Clary at his first COVID-19 vaccine dose appointment.
Provided by the Clary Family

The two-shot vaccine is currently only offered to those 18 and older.

“I want to help out other kids,’’ Clary said, according to the news outlet. “And it’s exciting to be one of the first my age to get the shot.”

He’s a rising fourth-grader from Cicero, a northern suburb of Syracuse.

Walker got his shot at an upstate hospital on Wednesday, his father, Bob Clary, told syracuse.com, with nothing more than a sore arm and a little disturbed sleep for his troubles.

In just under a month, he’s slated to get his second shot.

With his mom, dad, 14-year-old brother and 12-year-old sister all inoculated as well, Walker had no qualms about getting the jab.

“I’m not really worried about it at all,’’ he told Syracuse.com. “I don’t want to get COVID.”

His older brother, Jack, did the trial last year, his dad told The Post. “And we showed both of them the opportunity based on some information our pediatrician had posted,” he said.

“[Walker], like most kids, struggled being at home and not school last year, so I think he also knows this is an opportunity to help make sure kids across the country stay in school and sports,” he dad added.

The trial aims to “test the safety and effectiveness” of the Moderna vaccine for kids aged 6 months old to 12 years old.
Provided by the Clary Family
Walker with a backpack from the Moderna's KidCOVE study that he participated in.
Walker with a backpack from the Moderna’s KidCOVE study that he participated in.
Provided by the Clary Family

Clary got his shot at Upstate University Hospital in Kirkville, as part of Moderna’s KidCOVE study. Families are offered compensation to participate. Nearly 7,000 people are participating in the trial, Moderna said.

Moderna plans to recruit for the study by age — first going to kids 6 to 12, then kids 2 to 6, and lastly those ages six months to 2 years, the company said.

View original post